Development Pipeline

 DiscoveryPreclinicalPhase 1Phase 2Phase 3
 Discovery Preclinical Phase 1 Phase 2 Phase 3
Achillion Compounds      
PNH (oral)Complement Factor D Inhibitors  
aHUS (oral)Complement Factor D Inhibitor  
Dry AMDComplement Factor D Inhibitor  
Other complement diseases 

HCV: Janssen Collaboration      
odalasvir (ACH-3102)NS5A Inhibitor    
ACH-3422Nucleotide NS5B Polymerase Inhibitor   
SovaprevirNS3/4A Protease Inhibitor    

About Achillion

At Achillion, we are committed to applying our expertise of biology and structure-guided design and a deep understanding of patient and clinical needs to develop innovative treatment solutions aimed at improving patients' lives. More...

Research Realized

About our innovative research

Harnessing innovation to discover novel therapies is our passion. Click to learn more about our research.

No upcoming events at this time.

You are now leaving this website. If you would like to continue, click Continue.